Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.
about
Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.Decade in review-reproductive endocrinology: Understanding reproductive endocrine disorders.Ovarian kisspeptin expression is related to age and to monocyte chemoattractant protein-1Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation.A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome.Kisspeptin as a therapeutic target in reproduction.Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.The high responder: a review of pathophysiology and outcomes during IVF treatment.An update on the prevention of ovarian hyperstimulation syndrome.Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.Kisspeptin as a promising oocyte maturation trigger for in vitro fertilisation in humans.A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function.Kisspeptin/Kisspeptin Receptor System in the Ovary.Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different hormonal triggers of oocyte maturation in IVF treatment.Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte.Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.
P2860
Q33626546-AEFD68DC-77AB-4A7A-82AB-A9B3391E1383Q36404781-674CC455-62DD-4025-A1C0-FC27494B5FC5Q36758990-C9F7D6F8-4520-4928-BE8A-67228BE7F0C4Q37695823-82697AD5-6FB6-40F2-B808-B98210DC2672Q38371465-8BEFD359-790D-4503-8409-DBB0FDDA7BEBQ38631311-8E23B23B-5C2D-4A1E-8BFA-4277080EE7B9Q38647266-BC5508DB-3940-4F33-961A-68A2647BB940Q38653717-34DE794D-B780-4756-97B9-1480B3BCC96DQ38677963-2B6E8B3B-843D-4894-9521-D309346CE4C2Q38716011-0364A045-7613-4A9D-B7FB-661E1418467DQ38829575-9EA82DDC-86AD-4320-90AA-BEB12BF2C65FQ38876689-64D50715-1E90-4EFC-90F7-DA413EF1B0D4Q39231097-6C5F415D-4498-46AB-9915-4D777D931B3FQ46788717-7E476D3F-7D91-4B9E-8A85-C93DE4213012Q47200345-94854564-5313-45AE-A3D2-0AF5ECEDF9BDQ47550888-84D5FA19-F882-4F91-8779-2E4FDD075949Q49988311-3F9B5563-47C3-4D71-9F4F-26332A6B697DQ55009345-905D349F-0F4A-4E57-96F9-EA1240F9D582Q55022868-3D2ADFAD-6602-4CB8-8AC7-D3E9C0C4A8A8
P2860
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@ast
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@en
type
label
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@ast
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@en
prefLabel
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@ast
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@en
P2093
P2860
P50
P356
P1476
Efficacy of Kisspeptin-54 to T ...... o Fertilization (IVF) Therapy.
@en
P2093
Adam Buckley
Chioma Izzi-Engbeaya
Deborah A Ashby
Deborah Peters
Geoffrey H Trew
Georgios Christopoulos
Gurjinder M K Nijher
Julia K Prague
Matyas Szigeti
Rehan Salim
P2860
P304
P356
10.1210/JC.2015-2332
P407
P577
2015-07-20T00:00:00Z